Rapid sequence intubation

paleenui 5,752 views 21 slides Oct 25, 2012
Slide 1
Slide 1 of 21
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21

About This Presentation

No description available for this slideshow.


Slide Content

Paleerat Jariyakanjana , MD Emergency Physician Naresuan University Hospital Rapid Sequence Intubation

Decision to Intubate Failure to maintain or protect the airway failure of ventilation or oxygenation the patient’s anticipated clinical course and likelihood of deterioration

Administration of a potent sedative (induction) agent and an NMBA without interposed assisted ventilation positive-pressure ventilation  air to pass into the stomach  gastric distention  risk of regurgitation & aspiration

Requires preoxygenation phase permits pharmacologic control of the physiologic responses to laryngoscopy and intubation , mitigating potential adverse effects Increase ICP sympathetic discharge

Preparation assessed for intubation difficulty determining dosages and sequence of drugs, tube size, and laryngoscope type, blade and size continuous cardiac monitoring and pulse oximetry ≥1 good-quality IV lines Redundancy is always desirable in case of equipment or IV access failure.

Preparation

Preparation

Preoxygenation 100 % oxygen for 3 minutes of normal, tidal volume breathing normal, healthy adult establishes an adequate oxygen reservoir to permit 8 minutes of apnea before oxygen desaturation to less than 90% occurs “no bagging” time is insufficient 8 vital capacity breaths using high-flow oxygen

Pretreatment drugs are before administration of the succinylcholine & induction agent mitigate the effects of laryngoscopy and intubation on the patient’s presenting or comorbid conditions Intubation sympathetic discharge elevation of ICP reactive bronchospasm Bradycardia : children

Pretreatment

Paralysis with Induction rapid IV push immediately followed by rapid administration of intubating dose of NMBA wait 45 s from the time the succinylcholine is given to allow sufficient paralysis to occur

Paralysis with Induction Tintinalli's Emergency Medicine, 7e

Paralysis with Induction Tintinalli's Emergency Medicine, 7e

Paralysis with Induction Tintinalli's Emergency Medicine, 7e

Positioning The patient should be positioned for intubation as consciousness is lost. Sniffing position: head extension , neck flexion

Positioning Sellick’s maneuver application of firm backward-directed pressure over the cricoid cartilage minimize the risk of passive regurgitation and , hence, aspiration after administration of the induction agent and NMBA  BMV should not be initiated unless O2 sat ≤ 90%

Positioning

Placement of Tube assessed most easily by moving the mandible to test for absence of muscle tone O2 sat is approaching 90%, the pt may be ventilated When BMV is performed, Sellick’s maneuver is advisable As soon as the ETT is placed, the cuff should be inflated and its position confirmed

Postintubation Management CXR use of long-acting NMBAs (e.g., pancuronium , vecuronium ) toward optimal management using opioid analgesics and sedative agents to facilitate mechanical ventilation

Postintubation Management An adequate dose of a benzodiazepine (e.g., midazolam 0.1–0.2 mg/kg, IV) and an opioid analgesic (e.g., fentanyl , 3–5 μg /kg, IV, or morphine, 0.2–0.3 mg/kg, IV) is given to improve patient comfort and decrease sympathetic response to the ETT.

Any Questions?
Tags